PT1021183E - Combinacao de um antagonista selectivo para 5-htla e de um antagonista selectivo para hs-ht1b ou agonista parcial - Google Patents

Combinacao de um antagonista selectivo para 5-htla e de um antagonista selectivo para hs-ht1b ou agonista parcial

Info

Publication number
PT1021183E
PT1021183E PT98944374T PT98944374T PT1021183E PT 1021183 E PT1021183 E PT 1021183E PT 98944374 T PT98944374 T PT 98944374T PT 98944374 T PT98944374 T PT 98944374T PT 1021183 E PT1021183 E PT 1021183E
Authority
PT
Portugal
Prior art keywords
selective antagonist
htla
ht1b
combination
partial agonist
Prior art date
Application number
PT98944374T
Other languages
English (en)
Inventor
Seth-Olov Thorberg
Stefan Berg
Svante Ross
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT1021183E publication Critical patent/PT1021183E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT98944374T 1997-09-18 1998-09-09 Combinacao de um antagonista selectivo para 5-htla e de um antagonista selectivo para hs-ht1b ou agonista parcial PT1021183E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703374A SE9703374D0 (sv) 1997-09-18 1997-09-18 A new combination

Publications (1)

Publication Number Publication Date
PT1021183E true PT1021183E (pt) 2004-07-30

Family

ID=20408294

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98944374T PT1021183E (pt) 1997-09-18 1998-09-09 Combinacao de um antagonista selectivo para 5-htla e de um antagonista selectivo para hs-ht1b ou agonista parcial

Country Status (30)

Country Link
US (1) US6159972A (pt)
EP (1) EP1021183B1 (pt)
JP (1) JP2001516717A (pt)
KR (1) KR20010024075A (pt)
CN (1) CN1182847C (pt)
AR (1) AR015447A1 (pt)
AT (1) ATE261728T1 (pt)
AU (1) AU752718B2 (pt)
BR (1) BR9812234A (pt)
CA (1) CA2302383A1 (pt)
DE (1) DE69822490T2 (pt)
DK (1) DK1021183T3 (pt)
EE (1) EE04142B1 (pt)
ES (1) ES2216307T3 (pt)
HK (1) HK1032740A1 (pt)
HU (1) HUP0100401A3 (pt)
IL (1) IL134774A0 (pt)
IS (1) IS5408A (pt)
MY (1) MY116281A (pt)
NO (1) NO20001398L (pt)
NZ (1) NZ503174A (pt)
PL (1) PL339370A1 (pt)
PT (1) PT1021183E (pt)
RU (1) RU2215528C2 (pt)
SE (1) SE9703374D0 (pt)
SK (1) SK2842000A3 (pt)
TR (1) TR200000734T2 (pt)
TW (1) TW568786B (pt)
WO (1) WO1999013876A1 (pt)
ZA (1) ZA987810B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (en) * 2001-02-21 2002-08-29 Sankyo Company, Limited Chromene derivatives
WO2003007956A1 (en) * 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
USD969017S1 (en) 2021-06-28 2022-11-08 Koninklijke Asscher Diamant Maatschappij B.V. Rose marquise diamond article

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
FI961247A0 (fi) * 1996-03-18 1996-03-18 Finnish Peroxides Ab Oy Foerfarande foer loesning av uppsvaellningsproblem i en avfalls vattenreningsanordning foer kontroll av traodartiga bakterier
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
TR200000734T2 (tr) 2000-11-21
SE9703374D0 (sv) 1997-09-18
MY116281A (en) 2003-12-31
DE69822490D1 (de) 2004-04-22
HK1032740A1 (en) 2001-08-03
AR015447A1 (es) 2001-05-02
BR9812234A (pt) 2000-07-18
ES2216307T3 (es) 2004-10-16
HUP0100401A3 (en) 2003-01-28
EP1021183A1 (en) 2000-07-26
NO20001398D0 (no) 2000-03-17
CN1182847C (zh) 2005-01-05
AU752718B2 (en) 2002-09-26
EE04142B1 (et) 2003-10-15
TW568786B (en) 2004-01-01
WO1999013876A1 (en) 1999-03-25
IL134774A0 (en) 2001-04-30
JP2001516717A (ja) 2001-10-02
EE200000143A (et) 2001-02-15
ATE261728T1 (de) 2004-04-15
EP1021183B1 (en) 2004-03-17
PL339370A1 (en) 2000-12-18
IS5408A (is) 2000-03-15
NO20001398L (no) 2000-04-04
NZ503174A (en) 2002-03-01
DE69822490T2 (de) 2005-03-03
RU2215528C2 (ru) 2003-11-10
CN1279609A (zh) 2001-01-10
ZA987810B (en) 1999-02-18
HUP0100401A2 (hu) 2002-01-28
US6159972A (en) 2000-12-12
AU9192998A (en) 1999-04-05
SK2842000A3 (en) 2000-09-12
KR20010024075A (ko) 2001-03-26
DK1021183T3 (da) 2004-07-05
CA2302383A1 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
NO984772D0 (no) Tidlig evalueringssystem med boreevne
HK1124339A1 (en) 20-keto-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal activity 20--11-
ID29013A (id) Ligan-ligan reseptor novel thiroid dan metode ii
BR9712248A (pt) Antagonista receptores de vitronectina
LV11460A (lv) Estrogenu agonisti un antagonisti
BR9709938A (pt) Antagonistas dos receptores de il-8
DE69702040T2 (de) Schneideinsatz und Bohrer
PT1014985E (pt) Combinacao de um inibidor de reincorporacao de 5-ht e antagonistas de h5-ht 1b ou agonista parcial
DE69903961T2 (de) Muscarinagonisten und antagonisten
ATE266025T1 (de) Thrombin-rezeptor antagonisten
NO963331D0 (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
PT1021183E (pt) Combinacao de um antagonista selectivo para 5-htla e de um antagonista selectivo para hs-ht1b ou agonista parcial
ID27180A (id) Metode dan antarfasa akses layanan
BR9704413A (pt) Dispositivo e método anti-erosão para prevenção de erosão
DE69732715D1 (de) Tachykinin antagoniste
BR9710568A (pt) Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2
BR9602958A (pt) Dispositivo para a abertura de furos e/ou fendas
PT1077987E (pt) Propcesso para a preparacao de 4-desoxieritromicinas a e b
SI1021183T1 (en) A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST
BR1101094A (pt) Composto e antagonista receptor de glutamato
DE69830671D1 (de) Integrin-rezeptor-antagonisten
ES1037297Y (es) Poste para acotacion de areas transitables.
BR9701545A (pt) Cabeçote e agregado para furadeira múltiplas
BR7501646U (pt) Cobertura para área e fachada
IT1291587B1 (it) Treno di sbozzatura e metodo di sbozzatura relativo